The regulation of similar bio-therapeutic products varies widely among the different Latin American countries. While some of them are yet to introduce their own regulation, others — like Brazil and Mexico — have opened ways to cheaper, complex and safe biological treatment for patients. However, many things need improving and a lot of experience is still necessary to develop a mature LATAM Biosimilars Market.

Biosimilars Latam – Mexico 2018 is a unique and effective meeting point to share the information and experience Latin America’s Pharmaceutical Industry needs to develop a dynamic and thriving biosimilars market.

Join us in Mexico and trigger a quantum leap in Latin American Healthcare!

Who will
you meet?


More than:









Service Providers

Government Agencies

Industry Executives from Latam

From these areas:

  • Biosimilars
  • Biobetters
  • Biotechnology
  • Biotherapeutics
  • Analytical science
  • Regulatory compliance
  • Quality Control
  • Clinical immunology
  • Scientific Affairs
  • Pharmacovigilance
  • Research
  • Regulatory
  • Business Development
  • Marketing

Speaker Board

The Influence of the 257 Mexican Standard into the Biologic’s Market
Panel Discussion: Interchangeability Real Scenario
Biosimilars, The Mexican Industry Approach

With the new government and in order to achieve universal coverage, Mexico must focus on local production of Biotechnology Drugs, increasing its National Integration percentage and implement consolidated purchases for the health system

Panel: Current position of Regulatory Agencies after new government
Clinical Trials required for Biosimilars?
Interview: Industry Leaders and Their Strategy to Increase Biosimilar’s Access in the Region


Becton Dickinson and Company

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories.

General Electric Healthcare

As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services.


Codigo 46

Codigo 46 is a Mexican company focused on DNA analysis, providing the necessary tools for individuals and institutions looking for information about DNA.
They use Global Screeing Array Chip in 24 format, it is a panel of biomarkers detecting genetic variations, which are selected by world wide experts and some of them are selected specificly to the mexican population.

Photo Gallery 


Previous Forums

How to attend?

Keep me updated